Puma Biotechnology Inc (PBYI)
5.125
-0.06
(-1.06%)
USD |
NASDAQ |
Apr 23, 16:00
5.125
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price: 5.125 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 22, 2024 | 5.01 | 5.27 | 5.00 | 5.18 | 255165.0 |
Apr 19, 2024 | 4.92 | 5.08 | 4.90 | 5.01 | 290457.0 |
Apr 18, 2024 | 5.18 | 5.29 | 4.925 | 4.99 | 289054.0 |
Apr 17, 2024 | 5.10 | 5.30 | 5.05 | 5.17 | 248185.0 |
Apr 16, 2024 | 5.32 | 5.42 | 5.06 | 5.10 | 285862.0 |
Apr 15, 2024 | 5.30 | 5.43 | 5.25 | 5.35 | 266547.0 |
Apr 12, 2024 | 5.37 | 5.521 | 5.212 | 5.27 | 221709.0 |
Apr 11, 2024 | 5.51 | 5.65 | 5.46 | 5.49 | 145931.0 |
Apr 10, 2024 | 5.77 | 5.80 | 5.40 | 5.525 | 378662.0 |
Apr 09, 2024 | 5.61 | 6.055 | 5.59 | 5.83 | 552103.0 |
Apr 08, 2024 | 5.64 | 5.71 | 5.44 | 5.63 | 315266.0 |
Apr 05, 2024 | 5.49 | 5.84 | 5.42 | 5.66 | 405403.0 |
Apr 04, 2024 | 5.40 | 5.57 | 5.36 | 5.51 | 530286.0 |
Apr 03, 2024 | 5.24 | 5.35 | 5.10 | 5.35 | 337167.0 |
Apr 02, 2024 | 5.16 | 5.33 | 5.05 | 5.28 | 375493.0 |
Apr 01, 2024 | 5.42 | 5.42 | 5.12 | 5.28 | 400922.0 |
Mar 28, 2024 | 5.56 | 5.60 | 5.242 | 5.30 | 275380.0 |
Mar 27, 2024 | 5.63 | 5.74 | 5.38 | 5.58 | 357785.0 |
Mar 26, 2024 | 5.67 | 5.676 | 5.37 | 5.60 | 528485.0 |
Mar 25, 2024 | 5.31 | 5.72 | 5.25 | 5.59 | 738420.0 |
Mar 22, 2024 | 5.28 | 5.55 | 5.164 | 5.33 | 924299.0 |
Mar 21, 2024 | 4.67 | 5.39 | 4.62 | 5.35 | 1.168M |
Mar 20, 2024 | 4.40 | 4.74 | 4.24 | 4.695 | 599716.0 |
Mar 19, 2024 | 4.47 | 4.58 | 4.14 | 4.30 | 1.097M |
Mar 18, 2024 | 4.93 | 5.00 | 4.48 | 4.66 | 1.325M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.64
Minimum
May 11 2022
34.06
Maximum
Apr 24 2019
6.941
Average
6.28
Median
Mar 17 2020
Price Benchmarks
ADMA Biologics Inc | 6.535 |
Regeneron Pharmaceuticals Inc | 907.34 |
Sarepta Therapeutics Inc | 117.09 |
CytomX Therapeutics Inc | 1.68 |
Mirum Pharmaceuticals Inc | 24.39 |
Price Related Metrics
PE Ratio | 11.39 |
PS Ratio | 1.034 |
Price to Book Value | 4.623 |
Price to Free Cash Flow | 16.96 |
Earnings Yield | 8.78% |
Market Cap | 247.06M |
Operating PE Ratio | 7.325 |
Normalized PE Ratio | 11.08 |